Slide 1: Third Quarter 2024 Earnings
Third Quarter 2024 Earnings November 5, 2024 1
Slide 2: Safe Harbor Statement
Safe Harbor Statement Forward-Looking Statements: This presentation contains forward-looking statements within the meaning of federal securities laws, including, among others, statements about our expectations, plans, strategies or prospects. We generally use the words “may,” “will,” “expect,” “beli
Slide 3: Executive Summary
Executive Summary • Consolidated revenue was $505 million, representing 5% growth on a reported and constant currency(1) basis. o Healthcare revenue was $343 million, representing 12% growth on a reported and constant currency(1) basis. o Non-Healthcare revenue was $161 million, representing a 6% de
Slide 4: Third Quarter 2024 Actual vs. Guidance and Prior Year
Third Quarter 2024 Actual vs. Guidance and Prior Year(1) vs. Prior Year Q3 2024 Q3 2024 vs. Guidance Q3 2023 Constant ($ in millions; except EPS) Actual Guidance(2) Midpoint Actual As Reported Currency Healthcare Revenue $343 $340 1% $308 12% 12% Non-Healthcare Revenue $161 $165 (2%) $171 (6%) (6%)
Slide 5: Financial Performance | Third Quarter 2024 vs. Prior Year
Financial Performance | Third Quarter 2024 vs. Prior Year(1) Consolidated Revenue Healthcare Revenue Non-Healthcare Revenue $MM $MM $MM $171 $343 $161 $505 $479 $308 2023 2024 2023 2024 2023 2024 Third Quarter Third Quarter Third Quarter Non-GAAP Earnings Per Share(2) Healthcare Gross Margin(2) Non-
Slide 6: Year-to-Date 2024 Actual vs. Prior Year
Year-to-Date 2024 Actual vs. Prior Year(1) vs. Prior Year YTD 2024 YTD 2023 Constant ($ in millions; except EPS) Actual Actual As Reported Currency Healthcare Revenue $1,027 $936 10% 10% Non-Healthcare Revenue $467 $564 (17%) (16%) Consolidated Revenue $1,494 $1,499 (0%) 0% GAAP Gross Profit $760 $7
Slide 7: Financial Performance | Year-to-Date 2024 Actual vs. Prior Year
Financial Performance | Year-to-Date 2024 Actual vs. Prior Year Consolidated Revenue Healthcare Revenue Non-Healthcare Revenue $MM 0% Growth(1,2) $MM $MM $1,499 $1,494 $1,027 $564 $936 $467 2023 2024 2023 2024 2023 2024 Year-to-Date Through the Third Quarter Year-to-Date Through the Third Quarter Ye
Slide 8: Healthcare Performance | Year-to-Date 2024 Actual vs. Prior Year
Healthcare Performance | Year-to-Date 2024 Actual vs. Prior Year Incremental Value of New Contracts(1) Unrecognized Contract Revenue(2) Driver Installed Base(3) $MM, shown as reported $MM, shown as reported # of Units (MM) $1,652 $318 2.54 2.60 $1,435 $285 2023 2024 2023 2024 2023 2024 Year-to-Date
Slide 9: 2024 Financial Guidance | November 5, 2024
2024 Financial Guidance | November 5, 2024(1) Q4 2024 Guidance FY 2024 Guidance ($ in millions; except EPS) Low - High Low - High Healthcare Revenue $363 - $373 $1,390 - $1,400 Non-Healthcare Revenue $218 - $238 $685 - $705 Consolidated Revenue $581 - $611 $2,075 - $2,105 Healthcare Revenue Growth (
Slide 10: Appendix
Appendix GAAP to Non-GAAP Reconciliations 10
Slide 11: Consolidated Income Statement
Consolidated Income Statement (Unaudited; in millions, except per share data) (1),(2) Quarterly Performance Year to Date Full Year Q4 2024 Guidance (3) FY 2024 Guidance (3) Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 YTD 2023 YTD 2024 FY 2023 Low High Low High GAAP revenue $565.0 $455.3
Slide 12: Consolidated Income Statement
Consolidated Income Statement (Unaudited; in millions, except per share data) (1),(2) Quarterly Performance Year to Date Full Year Q4 2024 Guidance (3) FY 2024 Guidance (3) Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 YTD 2023 YTD 2024 FY 2023 Low High Low High GAAP non-operating income (
Slide 13: Segment Reporting
Segment Reporting (Unaudited; in millions, except percentages) (1,2) Quarterly Performance Year to Date Full Year Q4 2024 Guidance (3) FY 2024 Guidance (3) Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 YTD 2023 YTD 2024 FY 2023 Low High Low High Revenue Healthcare 346.7 281.1 307.8 339.9 3